Asia-Pacific Needle Biopsy Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Published Report
  • Aug 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 166
  • No of Figures: 53

Asia-Pacific Needle Biopsy Market, By Needle Type (Trephine Biopsy Needles, Klima Sternal Needle, Salah Needle Aspiration Needle, Jamshidi Needle and Others), Ergonomics (Sharp, Blunt, Quincke, Chiba, Franseen and Others), Procedure (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy), Sample Site (Muscles, Bones and Other Organs), Utility (Disposable and Reusable), Application (Tumour, Infection, Inflammation and Others), End User (Hospitals, Diagnostic Centers, Biopsy Labs, Ambulatory Surgical Centers, Academic and Research Organizations and Others), Distribution Channel (Direct Tender, Retail Sales), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2028.

Asia-Pacific Needle Biopsy Market Market Analysis and Insights: Asia-Pacific Needle Biopsy Market

The needle biopsy market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.4% in the forecast period of 2021 to 2028 and is expected to reach USD 311.21 million by 2028. Increased prevalence of breast cancer and lung cancer is expected to drive the needle biopsy market.

A needle biopsy is a manual, image-guided or ultrasound procedure used to obtain a sample of cells from the human body for laboratory or diagnostic testing, especially of the tumour. The common needle biopsy procedures include fine-needle aspiration biopsy and core needle biopsy. When a doctor identifies an abnormal lump or when the imaging scans show abnormalities in the body, then needle biopsy comes in place.

The rise in government initiatives and organizations is projected to drive the needle biopsy market’s growth. The increased cost of needle biopsies is expected to hinder the needle biopsy market growth. The increase in research and development activities will pave the way for lucrative opportunities for the needle biopsy market. The stringent rules and regulations are expected to pose as a challenge for the needle biopsy market.

The needle biopsy market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the needle biopsy market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Needle Biopsy Market Needle Biopsy Market Scope and Market Size

The needle biopsy market is segmented on the basis of the needle type, ergonomics, procedure, sample site, utility, application, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of needle type, the needle biopsy market is segmented into trephine biopsy needles, klima sternal needle, salah needle aspiration needle, jamshidi needle and others. In 2021, the trephine biopsy needles segment is expected to dominate the needle biopsy market due to its overall assessment of morphology and it is used as an alternative to fine needle biopsy.
  • On the basis of ergonomics, the needle biopsy market is segmented into sharp, blunt, quincke, chiba, franseen and others. In 2021, the sharp segment is expected to dominate the needle biopsy market due to its accurate detection and diagnosis of the cancer tumour.
  • On the basis of procedure, the needle biopsy market is segmented into fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided biopsy. In 2021, the fine-needle aspiration biopsy segment is expected to dominate the needle biopsy market since its minimally invasive.
  • On the basis of sample site, the needle biopsy market is segmented into muscles, bones and other organs. In 2021, the muscles segment is expected to dominate the needle biopsy market, since it provides the source of the disease process and a better diagnostic.
  • On the basis of utility, the needle biopsy market is segmented into disposable and reusable. In 2021, the disposable segment is expected to dominate the needle biopsy market since the needle biopsy can be used once and disposed of carefully and the chances of infection are less.
  • On the basis of application, the needle biopsy market is segmented into tumour, infection, inflammation and others. In 2021, the tumour segment is expected to dominate the needle biopsy market due to increased malignant tumour cases in breast cancer and lung cancer and ease of localization and detection.
  • On the basis of end user, the needle biopsy market is segmented into hospitals, diagnostic centres, biopsy labs, ambulatory surgical centres, academic and research organizations and others. In 2021, the hospitals segment is expected to dominate the needle biopsy market due to the increased need for lymphangioleiomyomatosis and the availability of needle biopsy to dominate the market.
  • On the basis of distribution channel, the needle biopsy market is segmented into direct tender and retail sales. In 2021, direct tender segment is expected to dominate the needle biopsy market due to the rise in access to fine-needle aspiration biopsies, the surge in the number of biopsies daily and the rise in the number of contacts for the supply of diagnostic medications and needle biopsy.

Asia-Pacific Needle Biopsy Market Country Level Analysis

Asia-Pacific needle biopsy market is analysed and market size information is provided by the country, needle type, ergonomics, procedure, sample site, utility, application, end user and distribution channel as referenced above.

The countries covered in the Asia-Pacific needle biopsy market report are the Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific.

China is expected to dominate the Asia-Pacific needle biopsy market due to increased awareness regarding the treatment for cancer and favourable reimbursement scenario for needle biopsy in China. The fine-needle aspiration biopsy segment is expected to dominate the market due to improvement in healthcare architecture in China and collaborations between healthcare organizations and market players.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growth Potential for Needle Biopsy in Emerging Economies and Strategic Initiatives by Market Players are creating new Opportunities in the Asia-Pacific Needle biopsy Market

The needle biopsy market also provides you with detailed market analysis for every country growth in particular industry with needle biopsy sales, impact of advancement in the needle biopsy and changes in regulatory scenarios with their support for the needle biopsy market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Needle Biopsy Market Share Analysis

The needle biopsy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the Asia-Pacific needle biopsy market.

The major companies covered in the Asia-Pacific needle biopsy market report are Boston Scientific Corporation, Cook, Hologic, Inc., ST. STONE MEDICAL DEVICES PVT. LTD., AprioMed AB, Amecath, Cardinal Health, BD, HAKKO Corporation, ARGON MEDICAL, Merit Medical Systems, Swastik Enterprise, B. Braun Melsungen AG among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product developments are also initiated by the companies worldwide which are also accelerating the growth of needle biopsy market.

For instance,

  • In January 2021, Hologic, Inc acquired SOMATEX Medical Technologies GmbH, a leader in biopsy site biomarkers, for USD 64.00 million. The acquisition funds Hologic, Inc’s strategy to deliver a varied range of novel solutions for the treatment of breast cancer. Hologic, Inc would be able to expand the breast cancer marker portfolio.

Partnership, joint ventures and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for needle biopsy through expanded range of size.

Customization Available : Asia-Pacific Needle Biopsy Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 2 ASIA-PACIFIC TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 ASIA-PACIFIC TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 4 ASIA-PACIFIC SALAH NEEDLE ASPIRATION NEEDLE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 ASIA-PACIFIC KLIMA STERNAL NEEDLE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 6 ASIA-PACIFIC JAMSHIDI NEEDLE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 ASIA-PACIFIC OTHERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)

TABLE 9 ASIA-PACIFIC SHARP IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 ASIA-PACIFIC BLUNT IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 ASIA-PACIFIC CHIBA IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 ASIA-PACIFIC FRANSEEN IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 ASIA-PACIFIC QUINCKE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 ASIA-PACIFIC OTHERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 16 ASIA-PACIFIC FINE NEEDLE ASPIRATION BIOPSY IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 ASIA-PACIFIC CORE NEEDLE BIOPSY IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 ASIA-PACIFIC IMAGE GUIDED BIOPSY IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 ASIA-PACIFIC VACUUM ASSITED BIOPSY IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 21 ASIA-PACIFIC BONES IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 ASIA-PACIFIC MUSCLES IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 ASIA-PACIFIC OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION

TABLE 24 ASIA-PACIFIC OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 25 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)

TABLE 26 ASIA-PACIFIC DISPOSABLE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 ASIA-PACIFIC REUSABLE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 29 ASIA-PACIFIC TUMOR IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 ASIA-PACIFIC TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 31 ASIA-PACIFIC INFECTION IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 ASIA-PACIFIC INFLAMMATION IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 ASIA-PACIFIC OTHERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 35 ASIA-PACIFIC HOSPITALS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 ASIA-PACIFIC DIAGNOSTIC CENTERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 ASIA-PACIFIC BIOPSY LABS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 ASIA-PACIFIC ACADEMIC AND RESEARCH ORGANIZATION IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 ASIA-PACIFIC OTHERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 41 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 42 ASIA-PACIFIC DIRECT TENDER IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 43 ASIA-PACIFIC RETAIL SALES IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 44 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

TABLE 45 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 46 ASIA-PACIFIC TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 47 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)

TABLE 48 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 49 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 50 ASIA-PACIFIC OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 51 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)

TABLE 52 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 53 ASIA-PACIFIC TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028(USD MILLION)

TABLE 54 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 55 ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 56 CHINA NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 57 CHINA TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 58 CHINA NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)

TABLE 59 CHINA NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 60 CHINA NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 61 CHINA OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 62 CHINA NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)

TABLE 63 CHINA NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 64 CHINA TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028(USD MILLION)

TABLE 65 CHINA NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 66 CHINA NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 67 INDIA NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 68 INDIA TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 69 INDIA NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)

TABLE 70 INDIA NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 71 INDIA NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 72 INDIA OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 73 INDIA NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)

TABLE 74 INDIA NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 75 INDIA TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028(USD MILLION)

TABLE 76 INDIA NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 77 INDIA NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 78 JAPAN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 79 JAPAN TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 80 JAPAN NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)

TABLE 81 JAPAN NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 82 JAPAN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 83 JAPAN OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 84 JAPAN NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)

TABLE 85 JAPAN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 86 JAPAN TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028(USD MILLION)

TABLE 87 JAPAN NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 88 JAPAN NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 89 AUSTRALIA NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 90 AUSTRALIA TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 91 AUSTRALIA NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)

TABLE 92 AUSTRALIA NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 93 AUSTRALIA NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 94 AUSTRALIA OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 95 AUSTRALIA NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)

TABLE 96 AUSTRALIA NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 97 AUSTRALIA TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028(USD MILLION)

TABLE 98 AUSTRALIA NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 99 AUSTRALIA NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 100 SOUTH KOREA NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 101 SOUTH KOREA TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 102 SOUTH KOREA NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)

TABLE 103 SOUTH KOREA NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 104 SOUTH KOREA NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 105 SOUTH KOREA OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 106 SOUTH KOREA NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)

TABLE 107 SOUTH KOREA NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 108 SOUTH KOREA TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028(USD MILLION)

TABLE 109 SOUTH KOREA NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 110 SOUTH KOREA NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 111 SINGAPORE NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 112 SINGAPORE TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 113 SINGAPORE NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)

TABLE 114 SINGAPORE NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 115 SINGAPORE NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 116 SINGAPORE OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 117 SINGAPORE NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)

TABLE 118 SINGAPORE NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 119 SINGAPORE TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028(USD MILLION)

TABLE 120 SINGAPORE NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 121 SINGAPORE NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 122 MALAYSIA NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 123 MALAYSIA TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 124 MALAYSIA NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)

TABLE 125 MALAYSIA NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 126 MALAYSIA NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 127 MALAYSIA OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 128 MALAYSIA NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)

TABLE 129 MALAYSIA NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 130 MALAYSIA TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028(USD MILLION)

TABLE 131 MALAYSIA NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 132 MALAYSIA NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 133 THAILAND NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 134 THAILAND TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 135 THAILAND NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)

TABLE 136 THAILAND NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 137 THAILAND NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 138 THAILAND OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 139 THAILAND NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)

TABLE 140 THAILAND NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 141 THAILAND TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028(USD MILLION)

TABLE 142 THAILAND NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 143 THAILAND NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 144 INDONESIA NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 145 INDONESIA TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 146 INDONESIA NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)

TABLE 147 INDONESIA NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 148 INDONESIA NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 149 INDONESIA OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 150 INDONESIA NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)

TABLE 151 INDONESIA NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 152 INDONESIA TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028(USD MILLION)

TABLE 153 INDONESIA NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 154 INDONESIA NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 155 PHILIPPINES NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 156 PHILIPPINES TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

TABLE 157 PHILIPPINES NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)

TABLE 158 PHILIPPINES NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 159 PHILIPPINES NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 160 PHILIPPINES OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)

TABLE 161 PHILIPPINES NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)

TABLE 162 PHILIPPINES NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 163 PHILIPPINES TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028(USD MILLION)

TABLE 164 PHILIPPINES NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 165 PHILIPPINES NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 166 REST OF ASIA-PACIFIC NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions